首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到17条相似文献,搜索用时 62 毫秒
1.
将海藻酸钠滴入壳聚糖和氯化钙的混合溶液中反应合成了海藻酸钙/壳聚糖(SA/CS)复合水凝胶材料,采用IR和SEM对其进行表征.讨论了壳聚糖分子量和含量对复合凝胶材料凝胶可注射性的影响.结果表明,复合材料中SA和CS存在分子间作用力;凝胶表面分布着同格,内部呈多孔结构}壳聚糖对复合凝胶的可注射性有明显的影响.  相似文献   

2.
李湘南  陈晓明  彭志明  李世普 《功能材料》2011,42(2):206-209,213
采用W/O/W复乳法制备空心羟基磷灰石(HAP)亚微球,将空心HAP亚微球均匀分布在壳聚糖/甘油磷酸钠(CS/GP)体系中制备可注射HAP/CS水凝胶(gel 1),同时制备可注射CS水凝胶(gel 2).用X射线衍射仪、场发射透射电镜、红外光谱、扫描电镜对空心HAP亚微球和水凝胶进行了表征,并比较分析了两种溶胶的成胶...  相似文献   

3.
近年来,基于水凝胶的导电材料及其作为柔性可穿戴设备的应用引起了人们的广泛关注。柔性可穿戴设备不仅可以采集人体生理信号用于远程健康监测,还在人机界面、软机器人等方面展示出巨大的应用潜力。导电水凝胶所具有的良好导电性、高延伸性、可调柔韧性、生物兼容性和多重刺激响应性等优点使其成为制备柔性可穿戴设备的理想材料。到目前为止,各种导电材料被广泛用于制作导电复合水凝胶。本文根据导电材料对导电复合水凝胶进行分类,包括离子导电水凝胶(基于盐离子、离子液体、聚电解质等导电物质)、电子导电水凝胶(基于导电聚合物基、碳材料、MXene和金属等导电物质)两大类,并介绍了导电水凝胶在人体运动监测、健康监测、人机界面等柔性可穿戴设备中的应用进展。  相似文献   

4.
采用物理共混的方法将氧化石墨烯(GO)均匀分散在海藻酸钠(SA)溶液中,通过Ca2+交联成功制备了SA及SA/GO凝胶球,采用红外光谱(FT-IR)、X射线衍射(XRD)、热重(TG)等表征其结构与性能,研究了微球的溶胀性能与吸附性能。结果表明,微球在pH值=7.4的缓冲溶液中的溶胀比明显高于pH值=1.2的溶液,具有pH值敏感性;随GO含量增大,微球的溶胀比呈下降趋势,而吸附量明显增加,对亚甲基蓝(MB)的最大吸附量达153.8 mg/g,去除率可达96.78%,对亚甲基蓝的吸附过程符合Langmuir吸附等温模型。  相似文献   

5.
为减少泊洛沙姆水凝胶的溶胶-凝胶转变温度对浓度的依赖性,以泊洛沙姆(P407)为基材,将己酰化乙二醇壳聚糖(HGC)与泊洛沙姆复合,制备了己酰化乙二醇壳聚糖/泊洛沙姆(HGC/P407)复合水凝胶,利用FTIR、SEM及试管反转法探讨了HGC/P407复合水凝胶的性能,并利用紫外-可见分光光度计(UV-vis)对HGC/P407复合水凝胶的体外药物缓释性能进行表征。结果表明,通过控制HGC的加入量,基于3%泊洛沙姆的HGC/P407复合水凝胶即可发生溶胶-凝胶转变现象,并使HGC/P407复合水凝胶的溶胶-凝胶转变温度处于32~37℃。HGC/P407复合水凝胶具有高度孔隙率,孔隙之间相互连通,孔径大小处于10~90μm的范围之内。HGC/P407复合水凝胶对抗癌药物吉西他滨的释药量达到82.4%~90.6%,缓释时间可达80 h左右。HGC/P407复合水凝胶在可注射药物载体领域具有重要的应用前景。  相似文献   

6.
7.
泊洛沙姆(poloxamer)是一种温敏性聚合物,在浓度为15.0%(质量分数,下同)~30.0%时可形成凝胶。为改善泊洛沙姆在体温下的成胶浓度和药物缓释性能,以泊洛沙姆407为基底,与新型温敏性乙酰化乙二醇壳聚糖复合,制得了温敏性乙酰化乙二醇壳聚糖/泊洛沙姆复合水凝胶。通过傅里叶变换红外光谱(FT-IR)、试管倒置法、旋转流变仪、扫描电子显微镜(SEM)和紫外-可见分光光度计(UV-vis)对乙酰化乙二醇壳聚糖/泊洛沙姆的结构、温敏性、力学性能、微观形貌和体外药物释放性能进行表征。结果表明,乙酰化乙二醇壳聚糖/泊洛沙姆溶液具有热可逆温敏性溶胶-凝胶转变行为。通过控制乙酰化乙二醇壳聚糖/泊洛沙姆的质量比,能够使溶胶-凝胶转变温度处于室温与体温(25~37℃)之间,缩短凝胶化时间(382s),降低泊洛沙姆407在体温下的成胶浓度(6%)。乙酰化乙二醇壳聚糖/泊洛沙姆复合水凝胶具有高度孔隙化的三维结构,其孔径大小处于10~60μm范围内,且表现出较高的力学性能。乙酰化乙二醇壳聚糖/泊洛沙姆复合水凝胶对抗癌药物吉西他滨具有缓释作用,载药凝胶的释药时间可达72 h。乙酰化乙二醇壳聚糖/泊洛沙姆复合水凝胶在可注射药物缓释载体方面具有重要的应用前景。  相似文献   

8.
9.
A new dosage form designed to provide parenteral drug delivery over a prolonged period of time following a standard injection has been investigated using testosterone as the model drug. The drug carrier consists of a biodegradable, biocompatible polymer in which the drug is dispersed on a molecular level. The polymer itself is formulated as a pseudolatex with high solid content (40.0%). The formulation has a low viscosity (97 cps) which can be injected easily through a hypodermic needle. The histopathology study showed good tissue compatibility of the pseudolatices and in-vivo tests on rats confirmed a prolonged release of drug over a 14 day period. The stability of the biodegradable poly-d, l-lactic acid latex was found not to be significantly changed over 120 days of storage at room temperature (25°). A six month study showed a slight increase (10%) in the viscosity of the parenteral product when stored at room temperature. The increase was attributed to partial coalescence of the polymer particles which had an initial diameter of 0.45 μm.  相似文献   

10.
以戊二醛为交联剂,制备了pH敏感性明胶-果胶水凝胶(GT-PT)和明胶-辛基果胶水凝胶(GT-OPT),研究了交联剂用量、温度、pH值对凝胶溶胀性能的影响及溶胀-消溶胀性能.结果表明,当温度在30~60℃时,凝胶的溶胀率随温度的升高而增大;且具有明显的pH敏感性,碱性条件下的溶胀率大于酸性条件下的溶胀率;不同pH值条件下,明胶-果胶水凝胶具有“形状记忆”功能.包埋在水凝胶中的牛血清蛋白在pH=1.0时的释药率大于pH=7.8和pH=9.18时的释药率.此类水凝胶有望用于蛋白质的pH值及温度控制释放.  相似文献   

11.
Injectable hydrogels are useful for numerous biomedical applications, such as to introduce therapeutics into tissues or for 3D printing. To expand the complexity of available injectable hydrogels, shear‐thinning and self‐healing granular hydrogels are developed from microgels that interact via guest–host chemistry. The microgel properties (e.g., degradation, molecule release) are tailored through their crosslinking chemistry, including degradation in response to proteases. When microgels of varied formulations are mixed, complex release and degradation behaviors are observed, including after injection to permit cellular invasion.  相似文献   

12.
为制备具有氧化还原和pH双响应性水凝胶,以甘蔗渣纤维素为原料,溶解在N,N-二甲基乙酰胺/氯化锂(DMAc/LiCl)溶剂体系中,然后在催化剂条件下,与乙酰乙酸叔丁酯(t-BAA)进行酯交换反应获得乙酰乙酸蔗渣纤维素(BCAA),然后与胱胺二盐酸盐(CYS)反应制得水凝胶.根据红外光谱和扫描电镜分析结果,表明已成功制备...  相似文献   

13.
Developing injectable nanocomposite conductive hydrogel dressings with multifunctions including adhesiveness, antibacterial, and radical scavenging ability and good mechanical property to enhance full‐thickness skin wound regeneration is highly desirable in clinical application. Herein, a series of adhesive hemostatic antioxidant conductive photothermal antibacterial hydrogels based on hyaluronic acid‐graft‐dopamine and reduced graphene oxide (rGO) using a H2O2/HPR (horseradish peroxidase) system are prepared for wound dressing. These hydrogels exhibit high swelling, degradability, tunable rheological property, and similar or superior mechanical properties to human skin. The polydopamine endowed antioxidant activity, tissue adhesiveness and hemostatic ability, self‐healing ability, conductivity, and NIR irradiation enhanced in vivo antibacterial behavior of the hydrogels are investigated. Moreover, drug release and zone of inhibition tests confirm sustained drug release capacity of the hydrogels. Furthermore, the hydrogel dressings significantly enhance vascularization by upregulating growth factor expression of CD31 and improve the granulation tissue thickness and collagen deposition, all of which promote wound closure and contribute to a better therapeutic effect than the commercial Tegaderm films group in a mouse full‐thickness wounds model. In summary, these adhesive hemostatic antioxidative conductive hydrogels with sustained drug release property to promote complete skin regeneration are an excellent wound dressing for full‐thickness skin repair.  相似文献   

14.
聚合物水凝胶是由亲水性聚合物链通过物理作用或化学键作用形成的三维网络结构,在受到环境变化刺激时会产生响应性,因而作为药物控释载体广泛应用于医药领域。文中介绍了可控释药系统的类型及其主要影响因素,综述了可控释药数学模型的发展与应用,比较性分析了经验/半经验模型与机理模型,并展望了未来的发展方向。  相似文献   

15.
16.
17.
Abstract

An in vitro batch dissolution method, simulating the in vivo pH-time profile was developed, using the USP XX dissolution apparatus. Significant correlation between in vitro dissolution data and bioavailability of the drug from the controlled release dosage form was obtained.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号